Lupus Research Alliance Awards $3 Million to Advance Pediatric Lupus Nephritis Diagnosis and Treatment
The Lupus Research Alliance (LRA) is pleased to announce that the 2023 Global Team Science Award (GTSA) has been...
Search Results
You searched for: lupus nephritis
Results found: 1150
Cyclosporine Worked Faster than Mycophenolate Mofetil or Azathioprine for Lupus Nephritis
June 12, 2019
A study presented at EULAR showed that ongoing maintenance therapy with the immunosuppressive drug cyclosporine helped lower...
ACR Released a Summary of the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis
The American College of Rheumatology (ACR) released a summary of the 2024 ACR Guideline for the Screening, Treatment, and...
Positive Data from Trial of Investigational Treatment KZR-616 for Lupus and Lupus Nephritis
June 3, 2020
Kezar Life Sciences, Inc. today announced updated results from the Phase 1b (Ph1b) portion of MISSION, a...
Gazyva® Shows Positive Results in Phase 3 Lupus Nephritis Trial
The Lupus Research Alliance (LRA) and clinical research affiliate Lupus Therapeutics (LT) are excited to share positive news of...
Lupus Therapeutics Announces Collaboration to Support the Evaluation of Non-Genetically Modified Cell-Based Therapy for Lupus Nephritis with Artiva Biotherapeutics
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a collaboration with Artiva Biotherapeutics, Inc. on...
Analysis Found Rituximab Biosimilar Showed Effectiveness in Treating Pediatric Lupus Nephritis
Rituximab biosimilar BCD020 showed effectiveness in treating lupus nephritis in a pediatric population according to results of a retrospective...
People with Lupus and Especially Lupus Nephritis at Higher Risk for Heart Disease, Study Shows
March 17, 2021
People with systemic lupus erythematosus (SLE) are at risk for cardiovascular diseases, and those with lupus nephritis...
FDA Expedites Existing Drug Gazyva for Lupus Nephritis
September 18, 2019
The LRA is pleased to share that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...
FDA Accepts Application for Gazyva® as Potential Lupus Nephritis Treatment
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is eager to share exciting news. The U.S....
Less Risk and Greater Efficacy in Pediatric Lupus Nephritis Treatment
November 3, 2020
There is no doubt about it. The research into the mechanisms of pediatric lupus nephritis conducted by...
Lupus Therapeutics Partners to Evaluate Potential Treatment for SLE and Lupus Nephritis Through North American Trial Network
NEW YORK, NY, June 2, 2023 — Lupus Research Alliance clinical research affiliate Lupus Therapeutics will collaborate with Novartis...